top of page

Stanford RNA Medicine Program

Who We Are

The Stanford RNA Medicine Program (RAMP) laboratory is at the forefront of advancing RNA-based research by providing cutting-edge technology support and resources. Our lab specializes in RNA functional element design, functional screens, RNA purification, and innovative delivery technologies, including lipid nanoparticles (LNP). The mission of RAMP is to bridge the gap between scientific discovery and clinical application, driving breakthroughs in precision medicine.

Our Process

A comprehensive, end-to-end workflow designed to accelerate discovery and ensure robust, reproducible results. 

Step 1

Mining viral genomes for functional RNA elements

Step 2

High-throughput cloning to generate complex RNA libraries

Step 3

Industry-grade production and purification of RNA

Step 4

Formulation with a variety of LNP compositions

Step 5

In vitro and in vivo testing to assess function 

Step 6

Data fed into sequence and structure to function modeling

RNA Platforms

We leverage a spectrum of RNA technologies, from established platforms to next-generation systems, to achieve optimal therapeutic outcomes. 

Established

mRNA

Established RNA technology, high expression with a wide range of applications.

Next Generation

Self amplifying RNA

Next generation technology, RNA with high expression at lower dose.

Next Generation

Circular RNA

Next generation technology, RNA with longer duration of expression.

Therapeutic Applications

Our platforms are versatile and can be applied across a broad range of therapeutic areas to address significant unmet medical needs.

Antigen discovery

Inflammation

Protein replacement therapies

Gene editing

Therapeutic delivery technologies

Cancer vaccines

Infectious disease vaccines

Capabilities

The RAMP Program is committed to groundbreaking discoveries and advancements in the field of medicine.

 

Our lab is equipped with advanced instrumentation

that supports a wide range of research, including:

Agilent HPLC 1260 Infinity II

Precise RNA and nucleic acid purification at prep or semi-prep scales.

Precision Nanosystems NanoAssemblr Ignite

Formulation of lipid nanoparticles.

Wyatt Technology DynaPro Plate Reader III

Assessment of size and stability of RNA and nanoparticle formulations.

Eppendorf Vacufuge Plus

Accelerates the evaporation of solvents under reduced pressure, allowing for rapid concentration without compromising sample integrity.

RNA Immunogenicity Assays

Evaluate immune response, assess the safety and efficacy of RNA constructs, and provide critical data for regulatory submissions.

bottom of page